Stuart Walter Peltz, Chief Executive Officer at PTC THERAPEUTICS, INC. (PTCT), sold 3,470 shares at $62.37 ($216K) on 2021-01-05, disclosed to the SEC on 2021-01-07.
Seasonal sale ($216k) by Chief Executive Officer — this insider has traded PTCT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.37 | 284 | $18K | 8.2% |
| 2 | $62.37 | 382 | $24K | 11.0% |
| 3 | $62.37 | 1,402 | $87K | 40.4% |
| 4 | $62.37 | 1,402 | $87K | 40.4% |
| Total | $62.37 avg | 3,470 | $216K | 100% |
| Filing → |
| PTCT | SELL | 2023-01-12 | $257K | — | Filing → |
| PTCT | SELL | 2023-01-11 | $160K | — | Filing → |
| PTCT | SELL | 2022-06-09 | $11K | — | Filing → |